|
1
|
Age
|
1.10 (1.01–1.20)
|
0.025
|
|
2
|
Bedridden time after hip fracture
|
1–12 month, 1.37 (0.21–8.80)
|
0.003
|
|
Reference, < 1 month
|
> 12 month, 8.60 (2.18–33.9)
|
|
3
|
Indwelling nasal feeding
|
9.16 (2.70, 31.1)
|
< 0.001
|
|
4
|
Number of hospitalizations in the past year
|
1.47 (1.09–1.98)
|
0.011
|
|
5
|
Days of hospitalization
|
1.04 (1.01–1.08)
|
0.027
|
|
6
|
Serum albumin level
|
0.79 (0.68–0.90)
|
< 0.001
|
|
7
|
Infection with drug-resistant fungus
|
7.55 (2.19, 26.1)
|
0.001
|
|
8
|
Infection with drug-resistant bacteria
|
10.7 (3.22–35.4)
|
< 0.001
|
|
9
|
Third-generation cephalosporins (without enzyme inhibitors)
|
3.17 (1.09–9.24)
|
0.034
|
|
10
|
Antibiotics need to be upgraded
|
7.68 (2.41–24.4)
|
< 0.001
|
|
11
|
Numbers of antibiotics upgrade M
|
2.27 (1.43–3.61)
|
< 0.001
|
|
12
|
Use of antifungal drugs
|
5.50 (1.81–16.7)
|
0.003
|
|
13
|
Use of glucocorticoids during antibiotic therapy
|
Oral, 5.06 (0.41–62.1)
|
< 0.001
|
|
Reference, not used
|
Intravenous, 81 (8.96–732)
|
|
14
|
Use of glucocorticoids
|
30.4 (6.81–135)
|
< 0.001
|
|
15
|
Parenteral nutrition support
|
8.43 (2.70–26.4)
|
< 0.001
|
|
16
|
Tracheal intubation or tracheotomy
|
4.86 (1.15–20.5)
|
0.031
|
